FDA Investigator Rasha Bamieh
Rasha Bamieh has conducted inspections on 339 sites in 3 countries as of 11 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
339
Last Inspection Date:
11 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
France,
Canada
FDA Investigators that have inspected at least one site in common with Rasha Bamieh:
Alanna L Mussawwir Bias,
Aldo J Quintana,
Alexandra A Carrico,
Amina Bashir,
Amy S Graf,
Andrea D Swingle,
Anthony R Petriella,
Armando Morales,
Art O Czabaniuk,
Ashley E Lewis,
Azza Talaat,
Barbara A Rusin,
Bernard P Heidt,
Bhakti Petigara Harp,
Bleta Vuniqi,
Brandi N Mcgrady,
Brian M Campbell,
Brian P Emanuel,
Brian P Hendrickson,
Brian P Putz,
Brittany A Mckenzie,
Byron Ho, DVM,
Calvin K Cook,
Cambria Cook Krueger,
Carl A Huffman, III,
Caroline H Le,
Carolyn J Oyster,
Cathie S Marshall,
CDR Kimberly Y Martin,
Cecelia G Vincent,
Charles E Frelix,
Chelsea J Falkowski,
Chelsea J Snider,
Christi L Bellmore,
Christian L Witkovskie,
Christina Eggleston,
Christine J Watts,
Christine M Rippinger,
Claire O Nicholls,
Constantin Y Philopoulos,
Courtney E Hillier,
Crystal L Parks,
Crystal M Young Lewis,
Cynthia L Aycock,
Cynthia Li,
Daniel B Arrecis,
Daniel J Gorski,
Daniel W Stoll,
Danny Tuntevski,
Darren S Morgan,
David A Paterson,
David L Wilson,
David P Moorhead,
Dawnna D Brown,
Deanna L Lampley,
Dennis R Downer,
Donald W Myrick,
Donna K Speer,
Dylan C Grippi,
Emilie E Kahn,
Emily J Orban,
Eric E Joneson,
Erica N Koory,
Erin M Miller,
Gary Durbiel Goldner,
Gary R Dzidowski,
Geneve M Parks,
George G Calafactor,
Greta L Budweg,
Hans T Meyers,
Hassan M Fakhreddine,
Henry A Wilson,
Hokenson,
Ifueko Osemwota,
Jacob A Clark,
James E Szelc,
Jeffrey D Meng,
Jeffrey O Hilgendorf,
Jennifer A Kemp,
John D Jaworski,
John N Woodall,
Joohi Castelvetere,
Joseph D Cooper,
Joseph R Haynes,
Joseph T Dougherty,
Joshua M Adams,
Judith A Jankowski,
Julia A Avery,
Julie A Silberberg,
Justin M Tomczak,
Katharine M Oaks,
Kathryn A Cutajar,
Kathryn A Guardiola,
Kathryn G Brown,
Keith J Jasukaitis,
Kelley L Clark,
Kelli L Wilkinson,
Kelly R Serfling,
Kip R Meleski,
Kristina Mezin,
Kristina Nastovski,
L'oreal F Walker,
Larry K Austin,
Laureen F Kononen,
Lauren A Crivellone,
Lauren E Burke,
Lauren E Sexton,
Linda S Jozefiak,
Lisa J Joseph,
Lisa J Renick,
Lisa M Thursam,
Lisa P Oakes,
LT Danielle S Mills,
LT Skip A Payne,
LTJG Aaron B Otis,
Lyle Wajda,
Mancia R Walker,
Margaret N Persich,
Maria C Iuga,
Mark E Parmon,
Marlon K Turner,
Martha Sullivan Myrick,
Martin R Vowell,
Matthew B Casale,
Matthew H Pitts,
Matthew J Gretkierewicz,
Matthew R Buenconsejo,
Megan C Amye,
Megan C Spencer,
Melissa M Tyrrell,
Michael A Moutray,
Michael S Budziak,
Michele L Forster, PhD,
Michelle L Jones,
Mikhail V Ovanesov, PhD,
Misty D Harvey,
Nancy A Bellamy,
Natalie A Mickelsen, DVM,
Neal D Singletary, PhD,
Neali H Lucas,
Nicholas E Boyd,
Nicholas J Presto,
Nicholas L Majerus,
Nicholas L Paulin,
Owens,
Paige E Shelborne,
Pamela J Weaver,
Patricia H Dlugosz,
Patrick B Cummings,
Patrick E Gainer,
Peyton B Greenwood,
Phenicia T Petty,
Rachel L Turley,
Rafeeq A Habeeb,
Rebecca A Olotu,
Rebecca E Dombrowski,
Reginald Walker,
Renee L Rice, PhD,
Richard T Riggie,
Robert G Taylor,
Robert P Whisenant,
Robert Rodriguez,
Roger A Hartman,
Rohn R Robertson,
Roshni J Patel,
Ryan J Benedict,
Sarah E Rhoades,
Sarah M Napier,
Sargum C Sood,
Sharlanda R Khosravi,
Sherri J Jackson,
Sherri L Clark,
Sneha S Patel,
Sonya M Lambkin,
Sullan,
Tammy M Phillips,
Theodore N Sietsema,
Thomas A Peter,
Tonnie L Carter,
Tracey L Siebesma,
Tracey L Taylor,
Travis S Bradley,
Twana R Chandler,
Tyra L Vanleer,
Tyson J Eldridge Stedman,
Vanessa J Colburn,
Vesa Vuniqi,
Victoria A Murray,
Wendy M Stark,
William C Gilbert,
William D Tingley,
William G Craig,
William G Nelson,
William R Brubaker
Rasha Bamieh's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2018 | FDA 483 Response | Flatout, Inc. - Form 483R, 2018-11-13 |
September, 2013 | EIR | DO & CO Detroit, Inc. - EIR, 2013-09-11 |
September, 2014 | FDA 483 | Southampton Flour Milling Inc - Form 483, 2014-09-24 |
February, 2008 | EIR | Burnette Foods, Inc - EIR, 2008-02-15 |
June, 2018 | FDA 483 Response | Home Style Foods, Inc. - Form 483R, 2018-06-21 |
November, 2017 | FDA 483 | TURANO KNEAD DOUGH BAKING CO - Form 483, 2017-11-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more